Arrowhead Pharmaceuticals, Inc. Revenue 2003–2025
Arrowhead Pharmaceuticals, Inc. reported $829.45M of revenue for fiscal 2025. That was 23258.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +842.6%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $829.45M | +23258.2% |
| FY 2024 | $3.55M | -98.5% |
| FY 2023 | $240.74M | -1.0% |
| FY 2022 | $243.23M | +75.9% |
| FY 2021 | $138.29M | +57.2% |
| FY 2020 | $87.99M | -47.9% |
| FY 2019 | $168.80M | +945.7% |
| FY 2018 | $16.14M | -48.6% |
| FY 2017 | $31.41M | +19736.5% |
| FY 2016 | $158,333 | -58.6% |
| FY 2015 | $382,000 | +118.3% |
| FY 2014 | $175,000 | -39.7% |
| FY 2013 | $290,266 | +97.6% |
| FY 2012 | $146,875 | -50.4% |
| FY 2011 | $296,139 | — |
| FY 2010 | $0 | — |
| FY 2009 | $0 | — |
| FY 2008 | $0 | — |
| FY 2007 | $0 | — |
| FY 2006 | $0 | — |
| FY 2005 | $0 | — |
| FY 2004 | $0 | — |
| FY 2003 | $0 | — |
Source: Arrowhead Pharmaceuticals, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ARWR 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Arrowhead Pharmaceuticals, Inc. reported $829.45M of revenue for fiscal 2025. That was 23258.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +842.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Arrowhead Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeArrowhead Pharmaceuticals, Inc. — frequently asked questions
What is Arrowhead Pharmaceuticals, Inc.'s revenue?
Arrowhead Pharmaceuticals, Inc. (ARWR) reported revenue of $829.45M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Arrowhead Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.